Gynecologic Oncologist, parent, advocate for patients with Gyn cancer. Opinions are mine not NYU Langone School of Medicine
- Tweets 1,409
- Following 599
- Followers 1,384
- Likes 1,022
Excited for this trial- a novel design with 3 studies in one protocol! Please enroll PSOC parpi progressors- nice efficacy! Data to be presented at ESMO. @GOG @Perlmutter_CC @gyncsm @SHARECancerSupt @SGO_org @ASCOPost @IGCSociety
To access this GOG-3133 FRAmwork-01 Podcast , click links in bio or go to:
GOG Podcast: ow.ly/Iw8K50ZRuhB
GOG YouTube: ow.ly/zpV950ZRuhE
#clinicaltrials #GOGF #GOGPartners #GOGF #ovariancancer #GCAM #IWishIKnew @EliLillyandCo @BPothuri
1
3
274
Bhavana Pothuri retweeted
Did you know? Genetic mutations that increase risk of ovarian, uterine & other cancers can be inherited from either biological parent, fathers as well as mothers. Learn more at bit.ly/4yeO8hE
ALT Image of a woman from our community with her daughter and husband at her daughter's graduation ceremony. OCRA's Ovarian & Gynecologic Cancer Awareness Month badge is at the top of the graphic. Text underneath photo reads: "Men carry and pass on genetic mutations which may increase risk of ovarian, uterine and other cancers for their children. Learn about genetic testing and prevention options. KNOW YOUR RISK. TAKE ACTION. ocrahope.org/ovcamonth"
3
2
113
Bhavana Pothuri retweeted
The latest episode of the GOG’s Accrual Culture series—Top Points for Site Selection—is now live on the GOG Podcast Channel, ow.ly/U9xL50ZQ6jn, and YouTube, ow.ly/Qa3l50ZQ6jo! #GOGF #GOGP #gynecologiconcology #clinicaltrials #GCAM #IWishIKnew
1
88
Bhavana Pothuri retweeted
We are excited to partner with @AmericanCancer for the Making Strides Against Breast Cancer walks Manhattan, Long Island, Brooklyn and Staten Island this October!
RSVP to walk with our PCC care teams: i.nyulangone.org/29o
@NYULangone @NYULangoneLI @NYULangoneBK
2
4
445
Bhavana Pothuri retweeted
Congratulations!
@nyulangone Named No. 1 Health System for 5th Consecutive Year by Vizient, making it the first health system to earn a top ranking in this category five years in a row.
prnewswire.com/news-releases…
1
16
47
3,429
Bhavana Pothuri retweeted
Proud of our @nyulangone Dean (and prior @Perlmutter_CC Director) Alec Kimmelman for his @Nature paper today:
Hepatocytes promote liver metastasis of #PancreaticCancer by providing serine
nature.com/articles/s41586-0…
With @BarDafna @RichPossemato @KoelinaG @nyugrossman
2
28
111
9,404
Bhavana Pothuri retweeted
Two weeks until OLN Great Debates in Solid Tumors arrives in NYC!
Meet some of the local oncology experts joining faculty from across the country to debate the questions shaping solid tumor care.
hmpglobalevents.com/olngreat…
#OLNGreatDebates
3
6
2,767
This is critical- we need advocacy to ensure increased funding for #endometrialcancer @gyncsm @SHARECancerSupt @ECANAwomen @ASCO @GOG @Perlmutter_CC
The House included $10M for Endometrial Cancer Research in the FY2027 defense appropriations bill but funding needs to make it to the final package. Show lawmakers why endometrial cancer research funding should be priority: sgo.org/news/sgo-launches-en… #FundEndometrialCancerResearch
1
4
302
Targeted therapies are reshaping advanced ovarian cancer care. Learn how to apply the latest evidence on PARP inhibitors, ADCs & emerging regimens with Drs. Bhavana Pothuri (@Bpothuri) & Premal Thaker: bit.ly/4buMQpH
Partnered with @NOCCNational
#OvarianCancer #SGO2026
5
13
280
Bhavana Pothuri retweeted
🔬 Four-year follow-up from the RUBY trial adds to the growing evidence supporting frontline immunotherapy in endometrial cancer!
Patients with dMMR/MSI-H primary advanced or recurrent disease continued to demonstrate durable benefit with dostarlimab + carboplatin/paclitaxel, reinforcing this regimen as a key treatment option.
#GynOnc #EndometrialCancer #SGO #Immunotherapy
Check it out here: tinyurl.com/35s7wayc
3
9
2,270
Bhavana Pothuri retweeted
🎙️ New listen: Updates in FDA Approvals for PARP Inhibitors in Ovarian Cancer. A clinical practice review, now available as a podcast from Gynecologic Oncology.
The panel unpacks how the PARPi approval landscape has shifted in ovarian cancer. This is essential listening for anyone making maintenance therapy decisions in clinic.
🎧 Listen via the journal's homepage: tinyurl.com/4w99scf7
#GynOnc #OvarianCancer #PARPinhibitors #SGO #OncologyEducation
2
5
387
📅 Applications for the LEAD Program close July 20! Invest in your future with a program focused on leadership development, mentorship, networking and professional growth in #GynecologicOncology. If you've been thinking about applying, now is the time. 🔗 ow.ly/hq6p50ZoVS4
1
2
376
Bhavana Pothuri retweeted
All investigators, fellows, and clinical research staff are welcome to attend. Registration invitations were sent via email . #GOGF #GOGPartners #UCAM #JUMP4JUNE
1
181
Bhavana Pothuri retweeted
Since OCRA launched the Living Lab in May, the response from our community has been inspiring. More than 450 people have consented to participate, from 44 states and the District of Columbia.
The Living Lab is OCRA's patient registry for people with uterine or ovarian cancer—a place to share experiences and health information that help researchers better understand these diseases and work toward improved care.
The more people who join, the more powerful the data becomes for researchers to answer questions that matter for patients today and in the future. Learn more at bit.ly/3SI2bMH
ALT Illustration of a woman on her laptop with flowers to one side. The background is peach, blue and teal. At the top of the graphic, the text reads: "More than 450 Living Lab particpants and growing!"
4
8
199
Bhavana Pothuri retweeted
Dr. Daniel R. Gomez, the new chair of Radiation Oncology at NYU Langone's @Perlmutter_CC, shares how molecular profiling is helping identify patients earlier and personalize treatment.
Read the full Q&A ⤵️ bit.ly/3Rc0QNN
2
4
610
Bhavana Pothuri retweeted
Congratulations to Jen - a great colleague and a leader for our program at Bellevue
Congratulations to Jennifer Wu, MD, on her highly deserved promotion to Professor of Medicine. “I treat each patient as a partner, and together, we work toward a common goal. Communication with my patients and their caregivers is essential to providing the best care.” —Dr. Wu
#Exceptionalism #FacultyAchievement #MedicalOncology #GICancer
@NYUGSOM_HemeOnc
@BellevueHosp
2
7
1,675
Bhavana Pothuri retweeted
💫 @myESMO #ESMOGynae2026: Six-year follow-up from the #GARNET trial highlights the long-term impact of #dostarlimab in dMMR/MSI-H #EndometrialCancer.
📍 ORR maintained at 45.5%
📍 CR rate increased to 22.4%
📍 Median DOR and OS still NR
📍 73.1% of responses ongoing at 6 years
@BPothuri @nyulangone #gyncsm #medtwitter #oncology
onclive.com/view/dostarlimab…
1
3
841
Bhavana Pothuri retweeted
All investigators, fellows, and clinical research staff are welcome to attend. Registration invitations were sent via email today. #GOGF #GOGPartners
1
132
Bhavana Pothuri retweeted
Cancer impacts every life. Join a webinar honoring the many faces of cancer, where survivors share their stories through and beyond diagnosis—highlighting the challenges, resilience & hope of life after cancer.
All are welcome: bit.ly/4dGjhmI
#CancerSurvivor #NCSD
1
3
6
1,433